MSA Nordic ApS
Private limited companyCVR 43915231IshøjActive
MSA Nordic ApS is a private limited company, based in Ishøj, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2023. Net profit rose 897% from 2024 to 2025, ending at DKK 339k. Equity grew to DKK 413k in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 418% (2024 → 2025), to DKK 1.8m.
- Net profit rose 897% (2024 → 2025), to DKK 339k.
- Equity rose 458% (2024 → 2025), to DKK 413k.
Employees
- 3 more employees than a year earlier: 7 (07/2026) against 4 (07/2025).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2023–2025 · amounts in DKK thousandEquity and net profit
| 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | – |
| Gross profit | – | 351 | 1,821 | +418.1% |
| Operating profit (EBIT) | 0 | 51 | 445 | +776.5% |
| Profit before tax | 0 | 45 | 440 | +869.9% |
| Net profit | 0 | 34 | 339 | +896.5% |
| Total assets | 40 | 233 | 1,448 | +520.7% |
| Equity | 40 | 74 | 413 | +457.7% |
| Liabilities | – | 159 | 998 | +526.1% |
| Cash and cash equivalents | 40 | 216 | 665 | +207.8% |
| Average number of employees | – | 2 | 4 | +100% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
3 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 23/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 09/05/2025 | The company | PDFXBRL |
| 2023 | 09/03/2023 – 31/12/2023 | 04/06/2024 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 32,911of 69,742 Better than 53% | No. 44,180of 69,964 Better than 37% |
| Same industry and fewer than 20 employees150 companies in the comparison | No. 101of 150 Better than 33% | No. 119of 150 Better than 21% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 6,144of 16,614 Better than 63% | No. 6,360of 16,661 Better than 62% |
| All companies of type ApS66,508 companies in the comparison | No. 31,854of 66,379 Better than 52% | No. 40,092of 66,505 Better than 40% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- MSA Nordic ApSDKK 1.8m
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- MSA Nordic ApSDKK 339k
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- MSA Nordic ApSDKK 413k
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- MSA Nordic ApS7
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Muhammed Ali Akbuga50%
- Adrian Sasivari50%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Adrian Sasivari | CEO | 18/03/2023 |
- Founders
- Muhammed Ali Akbuga, Adrian Sasivari
Former management (2)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Muhammed Ali Akbuga | Director | 09/03/2023 | 06/04/2023 |
| Adrian Sasivari | Director | 09/03/2023 | 17/03/2023 |
Signing rule: Selskabet tegnes af 1 direktør
Address and production units
1 active production unitsVejlebrovej 115
2635 Ishøj
| Production unit | Address | Employees | P number |
|---|---|---|---|
| MSA Nordic ApS | Vejlebrovej 115, 4. mf, 2635 Ishøj | 7 | 1029122284 |
Purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
The purpose is quoted from the register in Danish.
Changes year by year
11 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20251 changeaccounts 1
- AccountsAnnual report for 2024 published
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20238 changesmanagement 5 · founded 1 · ownership 2
- ManagementMuhammed Ali Akbuga stepped down as director
- ManagementAdrian Sasivari appointed ceo
- ManagementAdrian Sasivari stepped down as director
- FoundedRegistered as MSA Nordic ApS
- ManagementMuhammed Ali Akbuga appointed director
- ManagementAdrian Sasivari appointed director
- OwnershipMuhammed Ali Akbuga registered as owner (50%)
- OwnershipAdrian Sasivari registered as owner (50%)
Related companies
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.